Mark Wright

Mark Wright has a strong history of work experience in the pharmaceutical and healthcare industry. Mark is currently the Head of CMC at SFJ Pharmaceuticals, Inc. since December 2022. Prior to this, they served as the Head of Manufacturing, Biologics at Nordic Nanovector ASA from January 2019 to December 2022. From April 2013 to December 2018, they were the Site Lead at Piramal Healthcare UK. Mark also held various roles at Piramal Healthcare, including Head of Development from October 2012 to April 2013 and Process Development Manager from April 2012 to October 2012. Before that, they worked as a Principal Scientist at Piramal Health Care from June 2006 to April 2012. Mark began their career as a Project Scientist at Bio Products Laboratory from June 2003 to June 2006 and as a Clinical Scientist at Leicester Royal Infirmary from October 2001 to June 2003.

Mark Wright completed their BSc in Biochemistry from Imperial College London from 1995 to 1998. Mark then pursued a PhD in Biochemistry from the University of Leicester, which they completed from 1998 to 2001.